Impact of Prior Statin Therapy on 1-year Recurrence and Length of Hospitalization for Acute Idiopathic Pericarditis
William Nseir1, Lior Masika2, Adi Sharabi-Nov3
1Department of Internal Medicine A, Padeh Medical Center, Poriya, Israel, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Insights
Prior statin use in patients with acute idiopathic pericarditis (AIP) did not reduce 1-year recurrence but was associated with a longer length of hospitalization (LOH). Further research is needed to understand these findings in AIP patients.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Statins possess anti-inflammatory properties beyond lipid reduction.
- Acute idiopathic pericarditis (AIP) is an inflammatory condition of the pericardium.
Purpose of the Study:
- To investigate the impact of prior statin therapy on the clinical course of a first episode of AIP.
- Specifically, to assess effects on 1-year recurrence rates and length of hospitalization (LOH).
Main Methods:
- Retrospective study of 148 patients with a first episode of AIP (2015-2019).
- Patients were divided into two groups: those without statin use (n=117) and those with prior statin use (n=31).
- Comparison included age, comorbidities, laboratory data, 1-year recurrence, and LOH.
Main Results:
- Patients with prior statin use were significantly older (64.4 vs. 37.5 years, P < 0.01).
- Prior statin use was not associated with a reduced 1-year recurrence of pericarditis (P = 0.95).
- However, prior statin use was linked to a prolonged length of hospitalization (LOH) (P = 0.01).
Conclusions:
- Prior statin therapy does not appear to decrease the 1-year recurrence rate in patients experiencing their first episode of AIP.
- Conversely, statin use was associated with an increased length of hospitalization in this patient cohort.
Background:
Statins have anti-inflammatory effects that are independent of their lipid-lowering activity.
Objectives:
To examine whether prior statins therapy affects the clinical course of the first episode of acute idiopathic pericarditis (AIP) as the 1-year recurrence and length of hospitalization (LOH).
Methods:
This retrospective study included 148 subjects with first episode AIP admitted between the years 2015 and 2019. Data were collected from two hospitals in Northern Israel. We divided the patients in into two groups: 117 those without statins use and 31 those with prior statins use. We compared age, sex, co-morbidities, drugs, laboratory data, 1-year recurrence, and LOH.
Results:
The mean age of participants was 43.1 ± 19.4 years. Comparisons between subjects without statins and with prior statins use were made according to age (37.5 ± 16.7 years vs. 64.4 ± 12.7 years, P < 0.01), C-reactive protein (50 ± 40 vs. 48 ± 35 mg/dl, P = 0.9), LOH (5.4 ± 2.85 vs. 8.03 ± 4.92 days, P < 0.01), 1-year recurrence of pericarditis (23 vs. 6 cases, P = 0.95), respectively. Multivariate logistic regression analysis revealed that 1-year recurrence (odds ratio [OR] 0.8, 95% confidence interval [95%CI 0 0.6-1.1, P = 0.41), was not associated with prior statin use, while LOH (OR 2.56, 95%CI 2.08-2.75, P = 0.01) was prolonged with prior statins use in patients with first episode of AID.
Conclusions:
Prior statins use in patients with the first episode of AIP did not reduce the 1-year recurrence of pericarditis and prolong the LOH.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis IV: Nursing Management
Pericarditis I: Introduction
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care


